rAAV-Regulatory Elements FLAG
The FLAG tag is a short peptide sequence (DYKDDDDK) commonly used as an epitope tag in recombinant protein expression systems, including those involving rAAV vectors. It serves as a regulatory element for downstream protein detection and purification rather than influencing transcription or translation directly.
Function of the FLAG Tag in rAAV Systems:
- Protein Detection:
- The FLAG tag is recognized by highly specific antibodies, enabling easy detection of the expressed protein via techniques such as:
- Western blotting
- Immunofluorescence
- Enzyme-linked immunosorbent assay (ELISA)
- The FLAG tag is recognized by highly specific antibodies, enabling easy detection of the expressed protein via techniques such as:
- Protein Purification:
- Facilitates affinity purification using anti-FLAG antibody-conjugated beads or columns.
- Protein Tracking:
- Acts as a molecular marker to study protein localization, trafficking, and interactions.
Design and Integration of FLAG Tags in rAAV Vectors:
- N- or C-terminal Fusion:
- The FLAG tag is fused to the N- or C-terminus of the therapeutic or experimental protein without significantly altering its structure or function.
- Linker Usage:
- Flexible linkers are often added between the tag and the protein to avoid steric hindrance and maintain protein activity.
Applications of FLAG Tag in rAAV-Based Gene Therapy and Research:
- Therapeutic Protein Validation:
- Ensures proper expression and structural integrity of the therapeutic protein.
- Biological Research:
- Tracks protein expression and localization in tissues or cell cultures.
- Protein Interaction Studies:
- Identifies interacting partners through co-immunoprecipitation (Co-IP) or pull-down assays.
- Quality Control in Production:
- Facilitates monitoring during the production of rAAV-delivered proteins for clinical applications.
The FLAG tag is a simple yet powerful tool in rAAV systems for monitoring and purifying expressed proteins. Its versatility makes it an invaluable element in both therapeutic and research contexts.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|